Page last updated: 2024-10-27

fluoxetine and Carcinoma, Transitional Cell

fluoxetine has been researched along with Carcinoma, Transitional Cell in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, KY1
Lu, T1
Chang, CH1
Lo, YK1
Cheng, JS1
Wang, JL1
Chang, HT1
Jan, CR1

Other Studies

1 other study available for fluoxetine and Carcinoma, Transitional Cell

ArticleYear
Effect of fluoxetine on intracellular Ca2+ levels in bladder female transitional carcinoma (BFTC) cells.
    Pharmacological research, 2001, Volume: 43, Issue:5

    Topics: Calcium; Carcinoma, Transitional Cell; Cell Line; Estrenes; Female; Fluoxetine; Humans; Indicators a

2001